ECM
Endurant Capital Management Portfolio holdings
AUM
$17.4M
This Quarter Return
+25.85%
1 Year Return
+4.95%
3 Year Return
+16.8%
5 Year Return
+58.39%
10 Year Return
–
AUM
$277M
AUM Growth
+$277M
(-4.2%)
Cap. Flow
-$71.8M
Cap. Flow
% of AUM
-25.9%
Top 10 Holdings %
Top 10 Hldgs %
46.86%
Holding
81
New
21
Increased
12
Reduced
18
Closed
26
Top Buys
| 1 |
Becton Dickinson
BDX
|
$17.3M |
| 2 |
OXFD
Oxford Immunotec Global PLC Ordinary Shares
OXFD
|
$8.49M |
| 3 |
Cencora
COR
|
$7.66M |
| 4 |
Smith & Nephew
SNN
|
$7.55M |
| 5 |
Elutia
ELUT
|
$5.56M |
Top Sells
| 1 |
Encompass Health
EHC
|
$16.8M |
| 2 |
AdaptHealth
AHCO
|
$13.8M |
| 3 |
Integra LifeSciences
IART
|
$13.3M |
| 4 |
AbbVie
ABBV
|
$12.3M |
| 5 |
Ocular Therapeutix
OCUL
|
$11.3M |
Sector Composition
| 1 | Healthcare | 93.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
INBX
76
DELISTED
Inhibrx, Inc. Common Stock
INBX
| – | – |
-35,935
| Closed | -$647K |
|
77
iShares Russell 2000 ETF
IWM
$66.4B
| – | – |
0
| – | – |
|
78
McKesson
MCK
$85.7B
| – | – |
-40,419
| Closed | -$6.02M |
|
79
MacroGenics
MGNX
$121M
| – | – |
-97,374
| Closed | -$2.45M |
|
80
PetMed Express
PETS
$62.8M
| – | – |
-105,895
| Closed | -$3.35M |
|